Your patient is a 68-year-old male with a history of hypercholesterolemia currently taking atorvastatin (Lipitor®). He returns to you for his annual exam and is doing well. Based on his LDL-C, you...

Extracted text: Your patient is a 68-year-old male with a history of hypercholesterolemia currently taking atorvastatin (Lipitor®). He returns to you for his annual exam and is doing well. Based on his LDL-C, you would like to initiate treatment with alirocumab (Praluent). Using the FDA-approved prescribing information, drugs@FDA or any other site, and course materials, answer the questions below regarding the patient and the pharmacokinetic properties of alirocumab. Absorption Q. By what route is alirocumab administered? Q. Can monoclonal antibodies (mAbs) be administered orally? Explain your response. Q. What is the tmax of alirocumab?